also known receptor antagonist well selective receptor antagonist reported binding affinity ki nm selective receptor panel receptors enzymes transporters ion preclinical studies demonstrated efficacy relieving neuropathic pain pain sensitizing conditions associated improvement emotional negative developed esteve treatment neuropathic pain potentiation opioid analgesia successfully completed phase clinical trials showing good safety tolerability pharmacokinetic profile compatible day oral phase ii clinical trials currently underway making first selective receptor antagonist evaluated humans conditions drug article relating nervous system stub help wikipedia expanding